Table 2.
Group | |||||
---|---|---|---|---|---|
Normal (N = 6) |
Control (N = 6) |
Sham (N = 6) |
EA1 (N = 6) |
EA2 (N = 6) |
|
Ki67 (P) | 10.2 ± 11.4∗ | 122.0 ± 14.8∗ | 96.5 ± 13.2∗# | 47.0 ± 7.7#∗¶† | 110.0 ± 17.5∗ |
GFAP (P) | 16.5 ± 10.8 | 55.2 ± 16.4∗ | 49.8 ± 11.6∗ | 105.8 ± 13.8∗#¶† | 58.3 ± 8.5∗ |
Nestin (P) | 0.0 ± 0.0 | 290.7 ± 18.8∗ | 283.7 ± 23.2∗ | 92.3 ± 8.9∗#¶† | 219.7 ± 23.7∗#¶ |
Nestin (IC) | 0.00 ± 0.0 | 409.0 ± 37.5∗ | 395.2 ± 18.5∗ | 181.7 ± 21.9∗#¶† | 281.3 ± 22.5∗#¶ |
Data represent mean ± standard deviation. Normal: normal group; Control: control group; Sham: sham group; EA1: 2-Hz electroacupuncture treatment group; EA2: 15-Hz electroacupuncture group; Ki67: Ki67 immunoreactive cells; GFAP: GFAP immunoreactive cells; Nestin: nestin immunoreactive cells; P: penumbra area; IC: ischemic core area; ∗p < 0.001 compared with Normal; #p < 0.05 compared with Control; ¶p < 0.05 compared with Sham; †p < 0.05 compared with EA2; repeated measures analysis of variance, followed by Tukey's test.